Menu Search
Equities

Avanos Medical Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8HH:FRA

Avanos Medical Inc

Actions
  • Price (EUR)12.20
  • Today's Change0.40 / 3.39%
  • Shares traded1.26k
  • 1 Year change-23.75%
  • Beta1.0741
Data delayed at least 15 minutes, as of Feb 11 2026 07:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

  • Revenue in USD (TTM)699.90m
  • Net income in USD-468.60m
  • Incorporated2014
  • Employees2.23k
  • Location
    Avanos Medical Inc5405 Windward Parkway, Suite 100 SouthALPHARETTA 30004United StatesUSA
  • Phone+1 (678) 425-9273
  • Fax+1 (302) 636-5454
  • Websitehttps://avanos.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		AVNS:NYQ since
announced		Transaction
value
Nexus Medical LLCDeal completed15 Sep 202515 Sep 2025Deal completed21.19%--
Data delayed at least 15 minutes, as of Feb 11 2026 16:58 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.